A B S T R A C T Bile salts disrupt a functional "gastric mucosal barrier" increasing net forward-diffusion (+) of Na+ and back-diffusion (-) of H+. Studying canine Heidenhain pouches, we attempted to distinguish between two possible mechanisms for this effect: (a) mucosal uptake ofbile salt with subsequent cellular injury or (b ) dissolution ofmucosal lipids by intralumenal bile salt. A 10 mM mixture of six conjugated bile salts simulating the proportions found in human bile induced net Na+ flux of 15.5+3.2 and net H+ flux of -9.9±3.3 ,ueq/min. This change was accompanied by an increase in phospholipid efflux out ofgastric mucosa from a base-line value of 13.2+2.7 to 54.8+2.8 nmol/min (P < 0.001) and an increase in cholesterol efflux from 11.7+3.8 to 36.3+3.2 nmol/min (P< 0.001). Saturation with lecithin (25 mM) and cholesterol (50 mM) blocked disruption of the gastric mucosal barrier by bile salt (Na+ flux -1.2+±0.9, H+ flux 0.6±1.8 ,ueq/min). A 10 mM solution of taurodehydrocholate, a bile salt that does not form micelles, induced no net Na+ (-0.3 +0.8) or H+ flux (-0.7+1.4) and did not increase efflux of phospholipid (11.3+1.7) or cholesterol (10.4+2.0) over base line. Bile salt was absorbed from the mixture of six conjugates at 752±+85 nmol/min. Addition of subsaturation amounts of lecithin (4 mM) reduced bile salt absorption threefold to 252±+57 (P < 0.001), but abnormal Na+ flux (14.1+3.4) and H+ flux (-15.6±3.5) persisted. Taurodehydrocholate was absorbed to an intermediate extent (467 + 116). Dissolution ofmucosal lipids is apparently the mechanism by which bile salt disrupts the gastric mucosal barrier, and presumably at least one mechanism by which bile salt can injure the gastric mucosa.
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INTRODUCTION
Bile salts disrupt a "gastric mucosal barrier" that normally serves to impede movement of H+ from lumen into mucosa (1, 2) . This barrier is not well defined anatomically although it may correspond to the apical plasma membrane of the gastric mucosa (3) . Out of necessity, therefore, the barrier is defined in functional terms, and disruption of the barrier is said to have occurred when there is an increase in net flux of H+ out of the gastric lumen into the mucosa (back-diffusion), usually accompanied by net flux of Na+ into the lumen. This increased H+ back-diffusion can cause tissue injury ranging in animal models from gastritis to frank ulceration (4) (5) (6) (7) . In man these events may contribute to development of the gastritis that accompanies reflux of bile salt into the stomach after surgical interruption of the pyloric sphincter (8) (9) (10) .
The mechanism by which bile salts disrupt the gastric mucosal barrier is unknown. One possibility is that bile salt enters the mucosa, subsequently causing cellular injury. In support of this idea Davenport (11) has shown that taurocholate is absorbed from canine gastric pouches. However, there apparently has been no attempt to directly correlate this uptake with disruption of the mucosal barrier. A second possibility is that gastric mucosal damage is mediated through the detergent action of intralumenal bile salt. Two major constituents of mucosal membranes are phospholipid and cholesterol, which are both readily dissolved by bile salt micelles (12) . If such dissolution occurred, it would not be surprising to see an associated change in H+ and Na+ permeability. Indeed, Slota and Ammon (13) have provided evidence that dissolution of mucosal cholesterol is responsible for alteration ofjejunal water transport by bile salt. This study is an effort to distinguish between these two potential mechanisms for disruption of the gastric mucosal barrier: mucosal uptake of bile salt vs. dissolution of mucosal lipids by intralumenal bile salt micelles. METHODS Sodium salts of conjugated bile acids were purchased (Calbiochem-Behring Corp., American Hoechst Corp., San Diego, Calif.) and used without additional purification. Thin-layer chromatography of 100 ,g of each of these bile salts on silica gel G in a solvent system of butanol/acetic acid/water, 10:1:1 revealed a single band visualized with sulfuric acid charring. A chromatographic preparation of egg lecithin was obtained commercially (Sigma Chemical Co., St. Louis, Mo.) and shown to be pure by two-dimensional thin-layer chromatography (see below). Small quantities of phosphatidyl ethanolamine, phosphatidyl serine, phosphatidyl inositol, and cardiolipin for use as reference standards were also obtained from Sigma Chemical Co. Cholesterol was purchased (Eastman Kodak Co., Rochester, N. Y.) and shown to be without discernible impurity by thin-layer chromatography using ethyl ether/ heptane, 55:45 as the moving phase.
Radiolabeled where [Na+] , and V1 are concentration of Na+ and volume of test solution instilled into the pouch, and [Na+]0 and V0 are the concentration of Na+ and volume of test solution removed from the pouch after time, t. In early experiments V0 was determined in two ways: by direct measurement of volume removed from the pouch, and by dilution of ['4C]PEG in the instilled test solution. In the first 40 such double determinations, V0 by PEG dilution averaged 98.8% of V0 measured directly with a coefficient of variation of 2.8%. All calculations presented below are based on direct measurement of V0. Net flux defined by Eq. 1 also requires a small correction for residual volume in the pouches. Residual volume was measured on three separate occasions for each dog by emptying the pouches after an exhaustive saline wash, instilling a known volume of saline containing [14C]PEG, mixing thoroughly by barbotage, and measuring the dilution of 14C. Values in all dogs ranged from 0.55 to 2.1 ml and for any given dog did not vary by more than 0.5 ml. Therefore each dog's residual volume was assumed to be constant at that dog's average value. This value was multiplied by the change in [Nal] during the test period, divided by time, and added to the net flux calculated in Eq. 1. Correction for residual volume represented an increase in the calculated net flux of -5%. Finally, change in net Na+ flux induced by the bile acid solution was calculated by subtracting the mean prebile acid solution flux from the postbile acid solution flux. Change in mean net H+ flux was calculated in exactly analogous fashion.
Bile acid mass in solutions instilled into and removed from the Heidenhain pouches was determined by an automated procedure based on Talalay's enzymatic assay (15) as described in previous publications (16) . Mean uptake rate ofbile acid by the pouches was calculated according to Eq. 1 substituting concentrations of bile acid for concentrations of Na+. Taurodehydrocholate can not be measured by this enzymatic method. Uptake of this bile acid was determined using ["4C]-taurodehydrocholate of known specific activity. Scintillation counting in these experiments was performed in a 10:1 mixture of Aquasol (New England Nuclear) using a Packard Tricarb model 3330 (Packard Instrument Co., Inc., Downers Grove, Ill.).
Phospholipid and cholesterol efflux from the Heidenhain pouches was determined by performing a CHClJMeOH extraction on a 7.5 cm3 aliquot of the bile acid solution recovered from the pouches. The CHC13 phase was assayed for cholesterol by a gas-liquid chromatography procedure and for total phospholipid by standard techniques, both described (16 and H+ net flux observed after exposure to buffer alone as indicated by the dotted portion of the bars. All data presented subsequently have been corrected in similar fashion. The 10 mM BA solution significantly increased both Na+ forward-diffusion (P < 0.001) and H+ back-diffusion relative to the buffer (P < 0.01). TDHC had no such effect.
were corrected for the incremenit in net Na' and H+ flux attributable to the phosphate-l)uffered saline. This correction reduce(d the value for change in net Na+ flux to 15.5 ,ue(l/min and the value for change in net H+ flux to 9.9 /Le(q/min. A similar correction was applied in the calculation of all data reported below. That change in net Na+ forward-diffusion is not necessarily equal to change in net H+ back-diffusion has been observed by others (17) and suggests something other than simply one for one exchange of these two cations. Also shown in Fig. 1 is the result of a 40-min exposure of the pouches to a 10 miM solution of taurodehydrocholate. This bile salt, which does not form micelles (18) , had no effect on net Na+ flux (-0.3+0.8 gteq/min) or net H+ flux (-0.7±+1.4 ueq/n/min).
Effluxes of phospholipid and cholesterol from gastric mucosa into solutions in the pouch lumena are shown in Fig. 2 FIGURE 2 Efflux of phospholipid (solid bars) and cholesterol (stippled bars) from the mucosa of Heidenhain pouches during a 40-min exposure to the solutions indicated. The 10 mM bile salt (BA) solution increased efflux of phospholipid fourfold and cholesterol threefold as compared to buffer alone (P < 0.001 for both lipids). A 10 mM solution of taurodehydrocholate (TDHC) did not increase efflux of either lipid over values observed for buffer alone. Increased efflux of cholesterol relative to buffer persisted after addition of either 4 mM lecithin (PL) (P < 0.001) or saturation with 25 mM PL (P < 0.001). Increased efflux of phospholipid relative to buffer persisted after saturation with 10 mM (CH) (P < 0.001). This persistent increased efflux of phospholipid or cholesterol in the presence of saturation amounts of the other lipid provides an explanation for the continued capacity of these solutions to disrupt the gastric mucosal barrier since saturation with both lipids completely prevented such disruption (Fig. 3 ).
-lop -20L compared to buffer values for both). Lipid effluxes into 10 mM taurodehydrocholate were virtually identical to those into phosphate buffer, 11 .3+1.7 nmol/min for phospholipid and 10.4±2.0 nmol/min for cholesterol.
Analysis of individual phospholipids eluted into the 10 mM bile acid solution is presented in Table I . Lecithin constituted 52.7% of these phospholipids and its degradation product, lysolecithin, constituted another 9.6%. The remaining eluted phospholipid was largely phosphatidyl ethanolamine (19.7%) with smaller amounts of phosphatidyl serine, phosphatidyl inositol, and sphingomyelin. Comparison of these percentages to those of phospholipids extracted from gastric mucosa (Table I) suggests that a disproportionate amount of mucosal lecithin was eluted by the bile acid solution since only 43.2% of mucosal phospholipid was lecithin and none was lysolecithin.
Attempts to block bile acid-induced changes in Na+ and H+ net fluxes by addition of phospholipid and cholesterol are shown in Fig. 3 . Saturation ofthe 10 mM mixture of bile acids with 25 mM lecithin did not prevent alteration of Na+ forward-diffusion (11.8±2.1 ,ueq/min) or H+ back-diffusion (7.6±2.3 ,ueq/min). Saturation of the 10 mM bile acid mixture with cholesterol also was ineffective in preventing changes in Na+ forward-diffusion (17.4±2.6) and H+ back-diffusion (13.0± 1.9). However, saturation ofthe bile acid mixture with both lecithin and cholesterol completely prevented induction of Na+ forward-diffusion (-1.2±0.9) and H+ back-diffusion (0.6±1.8 ,ueq/min). An explanation for the continued injurious potential of bile acid solutions saturated with either lecithin or cholesterol alone may be found in Fig. 2 . These data show continued efflux of mucosal cholesterol (102.7±18.7 nmol/ min) into the solution saturated with lecithin and continued efflux of mucosal phospholipid (53.5±6.4 nmol/ min) into the solution saturated with cholesterol. (Fig. 2) . Saturation with both lipids completely prevented net forward-diffusion of Na+ and back-diffusion of H+ induced by 10 mM BA alone (Fig. 1 ).
Bile acid was absorbed by Heidenhain pouches from the 10 mM bile acid mixture at 752+86 nmol/min (Fig.  4) . Addition of subsaturation amounts of lecithin to this solution reduced bile acid absorption to 252±57 nmol/rnin (P < 0.001). Despite this threefold reduction in bile acid absorption, this solution induced net Na+ forward-diffusion of 14.1±3.4 geq/min and net H+ back-diffusion of 15.6±3.5 ueq/min, values as high or higher than those observed for 10 mM bile acid alone (Fig. 1) . Taurodehydrocholate was absorbed by the pouches to an intermediate extent (467±116 nmol/min, Fig. 4 ) despite its lack of effect on net Na+ and H+ fluxes (Fig. 1) . These data provide two separate instances of dissociation between bile acid uptake by the gastric mucosa and disruption of the gastric mucosal barrier.
DISCUSSION
In the present study three lines of evidence implicate micellar dissolution ofmucosal lipids as the mechanism by which bile salts disrupt the gastric mucosal barrier. First a mixture of conjugated bile salts, shown to increase H+ back-diffusion and Na+ forward-diffusion, increased efflux of phospholipid and cholesterol out of the gastric mucosa (Fig. 2) . Such efflux of phospholipid has also been reported by Thomas et al. (19) during exposure of rat gastric mucosa to solutions of sodium taurocholate. Second, the nonmicellar bile salt, taurodehydrocholate, did not alter net flux of either Na+ or H+ (Fig. 1) and did not increase either phospholipid or cholesterol efflux from the mucosa (Fig. 2) . Finally, (Fig. 1 ). Na+ and H+ induced by bile salt alone (Fig. 3) . This same bile salt mixture saturated with either phospholipid or cholesterol continued to promote efflux of the other lipid from the mucosa (Fig. 2) and continued to induce net forward-diffusion of Na+ and back-diffusion of H+ (Fig. 3) . These observations provide a firm indication that bile salts disrupt the gastric mucosal barrier by dissolving mucosal lipids and suggest that dissolution of either phospholipid or cholesterol is sufficient to induce this disruption.
If disruption of the gastric mucosal barrier is a detergent effect of intralumenal bile salt, such disruption should not occur below the critical micellar concentration (CMC) of bile salt mixed micelles. Unfortunately, much of the literature relevant to this issue is conflicting and incomplete. Taurocholate, the single bile salt most extensively studied, has been reported to have threshold concentrations for gastric mucosal injury of 1, 2, 10, and 15 mM (5) (6) (7) 20) . The first three of these estimates were obtained in acid solutions, for which we can find no published measurements of the CMC. The estimate of 15 mM was obtained in neutral solution where the CMC of taurocholate is -5 mM (21) . When compared in the same investigations, deoxycholates consistently produce gastric mucosal injury at lower concentrations than do cholates (5, 20) . This difference in potency is compatible with micelle-mediated injury since deoxycholates have lower CMC than cholates (21) . Finally we have previously reported that the same mixture of six conjugated bile salts employed in the present study must be concentrated above -2.5 mM before alteration of gastric mucosal flux of Na+ or H+ occurs (14) . We have also reported that CMC of this same mixture of bile salts in the presence of lecithin to be 0.5 mM (22) . These findings further strengthen the hypothesis that bile salts disrupt the gastric mucosal barrier by dissolving mucosal lipids.
The studies of Forte et al. (3) provide an anatomical correlate to our findings. Using electron-microscopic techniques they found that gastric mucosal damage after a 30-min exposure to deoxycholate was largely limited to the apical mucosal surface, as would be expected if intralumenal bile salt were responsible for the damage. These changes ranged from ruffling and pitting of the epithelial surface to denudation of apical epithelium. The authors concluded that the apical plasma membrane may be the primary anatomical gastric mucosal barrier. Since phospholipids and cholesterol are essential structural elements of such membranes, this conclusion, and the histological changes leading to it, are consistent with the hypothesis that bile salts injure the gastric mucosa by dissolving these membrane lipids.
The alternative to an intralumenal mechanism of injury is that bile salt enters the mucosal cells causing metabolic disruption manifested by changes in net fluxes of Na+ or H+. Our data and those of Davenport (11) certainly demonstrate that the gastric mucosa can absorb bile salt. However, two observations in the present study directly challenge the importance of this uptake in disruption of the gastric mucosal barrier. First, addition of subsaturation amounts of lecithin to the 10 mM bile salt mixture reduced mucosal uptake of bile salt threefold (Fig. 4) , but did not diminish bile salt effects on Na+ and H+ fluxes (Results). Second, taurodehydrocholate, which did not disrupt the gastric mucosal barrier (Fig. 1) , was absorbed by the gastric mucosa faster than was bile salt from the solution containing subsaturation amounts oflecithin (Fig. 4) . These observations strongly suggest that disruption ofthe gastric mucosal barrier is not an effect ofintramucosal bile salt.
Although dissolution of mucosal lipids appears to cause disruption of the gastric mucosal barrier, such dissolution may not be the only mechanism by which bile salt can injure the gastric mucosa. In vitro studies of isolated bullfrog gastric mucosa have shown that exposure of the serosal surface of this preparation to bile salt causes definite changes in both histological and electrical characteristics of the tissue (3, 5) . These changes, which differ from those after exposure of the mucosal surface to bile salt, could be a result of entry of bile salt into the mucosa or dissolution of lipids on the I 800r serosal surface of the tissue. Favoring the possibility that intramucosal bile salt causes some injury in this preparation is the observation that dehydrocholate, placed on the mucosal surface, causes changes in tissue electrical properties and H+ secretion resembling those caused by mucosal exposure to taurocholate (5). These changes are not likely to be a result of dissolution of mucosal lipids because dehydrocholate does not formn micelles (18) . This in vitro system, lacking the defense mechanisms and regenerative capacities of in vivo tissue, may be a particularly sensitive barometer for injurious effects ofbile salt. The importance of such effects in vivo, particularly under conditions of compromised tissue defenses, deserves further investigation.
This study stemmed from investigations into the pathogenesis of reflux gastritis after antrectomy and vagotomy (14) . Because most patients with that condition have an intragastric pH >5, we elected to perform our experiments at neutral, rather than acidic, pH. These experimental conditions also facilitated the study of a physiologic mixture of conjugated bile salts, most of which would precipitate at a pH <4 (21) . Assuming that under these conditions bile salts affect canine and human stomach similarly, our results suggest that the contribution of bile salts to the pathogenesis of reflux gastritis is mediated, at least in part, through dissolution of gastric mucosal phospholipid and cholesterol.
An additional advantage of using-neutral pH was that our results could be interpreted in light of physical-chemical characteristics of bile salts. Very few such data have been obtained at acidic pH, although it is known that taurodeoxycholic acid can form micelles at pH 2 (21) . One disadvantage of this experimental design is that results obtained at neutral pH are of uncertain relevance to the pathogenesis of gastric ulcer disease, a condition to which reflux of bile salt is thought to contribute, but in which gastric pH is often quite acidic (23, 24) . Confident assessment of the importance of mucosal lipid dissolution in the pathogenesis of gastric ulcer disease will require study of both gastric toxicity and physical-chemical characteristics for bile salts at acid pH.
